Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, NC, United States of America.
UNC Project Malawi, Lilongwe, Malawi.
PLoS One. 2023 Mar 16;18(3):e0282016. doi: 10.1371/journal.pone.0282016. eCollection 2023.
While mental health stigma research is sparse in Malawi, research in other settings suggests that stigma represents a barrier to mental health treatment and recovery. Accordingly, we conducted an analysis to understand the role of treatment-related stigma in depression care in Malawi by estimating the effect of patients' baseline anticipated treatment-related stigma on their 3-month probability of depression remission when newly identified with depression.
We conducted depression screening and treatment at 10 noncommunicable disease (NCD) clinics across Malawi from April 2019 through December 2021. Eligible cohort participants were 18-65 years with depressive symptoms indicated by a PHQ-9 score ≥5. Questionnaires at the baseline and 3-month interviews included a vignette-based quantitative stigma instrument that measured treatment-related stigma, i.e., concerns about external stigma because of receiving depression treatment. Using inverse probability weighting to adjust for confounding and multiple imputation to account for missing data, this analysis relates participants' baseline levels of anticipated treatment stigma to the 3-month probability of achieving depression remission (i.e., PHQ-9 score < 5).
Of 743 included participants, 273 (37%) achieved depression remission by their 3-month interview. The probability of achieving depression remission at the 3-month interview among participants with high anticipated treatment stigma (0.31; 95% Confidence Interval [CI]: 0.23, 0.39)) was 10 percentage points lower than among the low/neutral stigma group (risk: 0.41; 95% CI: 0.36, 0.45; RD: -0.10; 95% CI: -0.19, -0.003).
In Malawi, a reduction in anticipated depression treatment-related stigma among NCD patients initiating depression treatment could improve depression outcomes. Further investigation is necessary to understand the modes by which stigma can be successfully reduced to improve mental health outcomes and quality of life among people living with depression.
虽然马拉维的心理健康污名研究很少,但其他环境中的研究表明,污名是精神卫生治疗和康复的障碍。因此,我们进行了一项分析,以了解治疗相关污名在马拉维抑郁症护理中的作用,方法是估计患者基线时对治疗相关污名的预期对新诊断为抑郁症的患者在 3 个月时抑郁缓解的可能性的影响。
我们于 2019 年 4 月至 2021 年 12 月在马拉维的 10 个非传染性疾病(NCD)诊所进行了抑郁症筛查和治疗。合格的队列参与者为 18-65 岁,PHQ-9 评分≥5 分表示有抑郁症状。基线和 3 个月访谈时的问卷包括一个基于案例的定量污名工具,用于测量与治疗相关的污名,即因接受抑郁症治疗而对外界污名的担忧。使用逆概率加权调整混杂因素,用多重插补处理缺失数据,本分析将参与者的基线预期治疗污名水平与 3 个月时实现抑郁缓解的概率(即 PHQ-9 评分<5)联系起来。
在 743 名纳入的参与者中,有 273 名(37%)在 3 个月访谈时达到抑郁缓解。高预期治疗污名组(0.31;95%置信区间[CI]:0.23,0.39)在 3 个月访谈时达到抑郁缓解的概率比低/中性污名组低 10 个百分点(风险:0.41;95%CI:0.36,0.45;RD:-0.10;95%CI:-0.19,-0.003)。
在马拉维,减少开始治疗抑郁症的 NCD 患者对治疗相关抑郁症污名的预期,可能会改善抑郁症的结果。需要进一步调查,以了解如何成功减少污名,从而改善抑郁症患者的心理健康结果和生活质量。